Eli Lilly and Company (LLY) Set to Launch Oral Obesity Drug in Q2, Reuters Reports
Reuters reported on March 2 that Eli Lilly and Company (NYSE:LLY) CFO Lucas Montarce stated that the company is making preparations to launch its new oral obesity drug, orforglipron, in the United ...






